MedPath

IBUPROFEN CAPSULES, 200 MG

IBUPROFEN CAPSULES, 200 MG

Approved
DIN Number

02489759

Drug Class

Human

Market Date

N/A

Company
HC

Catalent Ontario Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02489759
AIG Number0108883004
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
M01AE01 IBUPROFEN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

IBUPROFENActive
Strength: 200 MG
Monograph: IBUPROFEN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.